LF Asia's healthcare business to become DCH Auriga

Serving the healthcare industry with a dedicated Asian distribution platform

(Hong Kong, 18 October 2017) Following the acquisition of LF Asia Ltd. ("LF Asia") and its subsidiaries by Dah Chong Hong Holdings Limited ("DCH", stock code: 1828.HK) in July 2016, the LF Asia healthcare and consumer goods distribution operations will be realigned under dedicated management to prepare for growth across the region. As of 1 Nov 2017, LF Asia's healthcare business will change its name to DCH Auriga Ltd.

Under the new name, DCH Auriga will continue to partner with world leading healthcare companies to bring medical products and treatments to Asia by offering end-to-end solutions including regulatory and medical liaison support, sales and marketing, commercial services, warehousing and logistics in Hong Kong, Macau, China, Singapore, Malaysia, Indonesia, Thailand and the Philippines.

The name "Auriga" is adopted from a constellation depicting a charioteer, symbolising the business's commitment to agility and dedication to guiding clients through the complexities of dynamic markets. DCH Auriga pairs deeply rooted relationships and intrinsic local expertise with cutting edge technologies that drive flexibility and transparency in the supply chain. This rich expertise is complimented by a dedication to partnership and the belief that customised solutions create optimised supply chains. Teams of in-market professionals deliver innovative solutions and actionable insights to enable our partners to deliver the best possible care to those in need.

Mr. Tim Collins, CEO of DCH Auriga, commented, "This restructuring will enable DCH Auriga to focus on better serving our strategic partners across the region and meet the unique and complex requirements of Asia's healthcare communities. With the support of DCH and CITIC Pacific Limited, we are positioned for dynamic growth."

About DCH Auriga

DCH Auriga is an an Asia-based integrated market management provider specialising in healthcare. Offering comprehensive commercial and logistics solutions, DCH Auriga partners with the world's leading healthcare companies to distribute pharmaceuticals, medical devices, surgical equipment, diagnostics and OTC products for more than 500 brands into hospitals, pharmacies and specialty stores across Asia. DCH Auriga is a subsidiary of Dah Chong Hong Holdings Limited (stock code: 1828.HK) with operations in Hong Kong, Macau, China, Singapore, Malaysia, Indonesia, Thailand and the Philippines. For more details, please visit www.dchauriga.com.

About DCH

Dah Chong Hong ("DCH", stock code: 1828.HK) is an integrated motor and consumer products distribution company operating in Asia with an extensive logistics network. DCH is a leading distributor and dealer of motor vehicles in Greater China and provides a full range of motor related services including maintenance, rental, repair and financing. DCH's consumer products business includes the trading, distribution and retail of food and FMCG, healthcare and electronic products.

Dedicated to bringing to quality products to consumers across Asia, DCH is the preferred partner of over 1,000 brands from more than 30 countries with operations in 10 Asian economies.

DCH is a subsidiary of China's largest conglomerate CITIC Limited (stock code: 0267.HK), DCH employs over 17,000 staff across the region. For more details, please visit www.dch.com.hk.

Media Enquiries:

Ms. Gwen Walters

(852) 2768 2017

gwenwalters@dch-holding.com

Ms. Katherine Tung

(852) 2768 2585

katherinetung@cccm.dch.com.hk